The New Zealand Drug Foundation has been in the forefront of drug policy debates in New Zealand for more than 25 years. We interviewed its director, Ross Bell, about the chances of reforming drug laws in his country.
The Catalonian parliament has recently adopted a new law to regulate the cannabis market. We interviewed Òscar Parés, the deputy director of the International Center for Ethnobotanical Education, Research & Service to learn more about the cannabis reconquista movement in Spain.
Although it was without much fanfare that the European Commission, in July 2017, published the new Action Plan on Drugs (2017-2020), the drug policy community should celebrate it as a great achievement both for its progressive content and for the meaningful involvement of civil society in its preparation. [There is a Polish, Estonian, Hungarian and Serbian […]
“The question is no longer whether cannabis will be legalized, but when.” Watch this 3 minutes animated video clip produced by a member of our global video network, CILD, explaining why cannabis should be legalized in Italy!
While the federal government of Germany does not dare to change cannabis laws, cities like Berlin and Düsseldorf are taking over the lead in reform. We interviewed Georg Wurth, the chairman of the German Cannabis Association about the situation.
In February 2016, Macedonia legalised medicinal cannabis but the law is far from ideal. Drugreporter’s Macedonian partner, Healthy Options Project Skopje – HOPS – carried out an analysis of the law. Read their key remarks and recommendations presented by Vlatko Dekov.
Marco Perduca is a leading cannabis reform advocate in Italy and he was one of the first civil society representative who spoke up against the drug conventions at the UN Commission on Narcotic Drugs. We interviewed him about the prospects of cannabis law reform in Italy.
In June 2016, an amendment to the Bulgarian Narcotic Substances and Precursors Control Act came into force. Read the notes of an eye-witness.
Every cannabis smoker knows that the major psychoactive ingredient of the plant is Δ9-tetrahydrocannabinol (THC), but there is also a range of other chemicals in marijuana smoke. One of the other significant components is cannabidiol (CBD). Anecdotal evidence suggests that CBD can inhibit some negative side effects associated with marijuana, but does this claim stand […]
Leading national and international experts and activists discussed barriers and opportunities at the first conference on medical cannabis in Hungary.